Sector Gamma AS’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.17M | Buy |
+121,128
| New | +$6.58M | 1.12% | 31 |
|
|
2023
Q2 | – | Sell |
-162,397
| Closed | -$8.12M | – | 32 |
|
|
2023
Q1 | $8.12M | Sell |
162,397
-132,387
| -45% | -$6.24M | 1.97% | 18 |
|
|
2022
Q4 | $13.6M | Sell |
294,784
-92,400
| -24% | -$4M | 3.12% | 14 |
|
|
2022
Q3 | $15M | Sell |
387,184
-145,551
| -27% | -$5.84M | 3.86% | 11 |
|
|
2022
Q2 | $19.9M | Buy |
532,735
+137,400
| +35% | +$5.59M | 4.44% | 7 |
|
|
2022
Q1 | $17.5M | Sell |
395,335
-104,195
| -21% | -$4.52M | 3.8% | 8 |
|
|
2021
Q4 | $21.2M | Sell |
499,530
-103,152
| -17% | -$4.33M | 4.99% | 7 |
|
|
2021
Q3 | $26.1M | Buy |
602,682
+166,276
| +38% | +$7.36M | 5.22% | 4 |
|
|
2021
Q2 | $18.7M | Buy |
436,406
+54,870
| +14% | +$2.31M | 3.31% | 12 |
|
|
2021
Q1 | $14.7M | Sell |
381,536
-308,746
| -45% | -$11.7M | 2.7% | 17 |
|
|
2020
Q4 | $24.8M | Buy |
690,282
+135,280
| +24% | +$4.88M | 4.72% | 6 |
|
|
2020
Q3 | $21.2M | Sell |
555,002
-156,480
| -22% | -$6.03M | 4.83% | 8 |
|
|
2020
Q2 | $25M | Sell |
711,482
-259,500
| -27% | -$9.35M | 5.16% | 6 |
|
|
2020
Q1 | $31.7M | Sell |
970,982
-66,041
| -6% | -$2.58M | 6.76% | 3 |
|
|
2019
Q4 | $46.9M | Sell |
1,037,023
-71,313
| -6% | -$2.98M | 7.51% | 3 |
|
|
2019
Q3 | $45.1M | Hold |
1,108,336
| – | – | 7.62% | 2 |
|
|
2019
Q2 | $47.6M | Sell |
1,108,336
-6,838
| -0.6% | -$263K | 7.66% | 3 |
|
|
2019
Q1 | $42.8M | Sell |
1,115,174
-193,200
| -15% | -$7.38M | 6.86% | 3 |
|
|
2018
Q4 | $46.2M | Sell |
1,308,374
-75,000
| -5% | -$2.72M | 7.77% | 3 |
|
|
2018
Q3 | $53.3M | Sell |
1,383,374
-77,926
| -5% | -$2.72M | 8.35% | 3 |
|
|
2018
Q2 | $47.8M | Sell |
1,461,300
-280,080
| -16% | -$8.45M | 7.94% | 5 |
|
|
2018
Q1 | $47.6M | Buy |
1,741,380
+40,500
| +2% | +$1.1M | 8.57% | 2 |
|
|
2017
Q4 | $42.2M | Buy |
1,700,880
+232,000
| +16% | +$6.4M | 7.09% | 3 |
|
|
2017
Q3 | $42.8M | Buy |
1,468,880
+31,400
| +2% | +$867K | 6.53% | 4 |
|
|
2017
Q2 | $39.8M | Buy |
1,437,480
+13,600
| +1% | +$361K | 5.79% | 5 |
|
|
2017
Q1 | $35.4M | Buy |
1,423,880
+168,300
| +13% | +$4.09M | 5.63% | 6 |
|
|
2016
Q4 | $27.2M | Buy |
1,255,580
+700
| +0.1% | +$15.3K | 5.11% | 6 |
|
|
2016
Q3 | $27.7M | Sell |
1,254,880
-157,290
| -11% | -$3.75M | 4.84% | 7 |
|
|
2016
Q2 | $33M | Sell |
1,412,170
-354,080
| -20% | -$7.66M | 6.27% | 3 |
|
|
2016
Q1 | $33.2M | Buy |
1,766,250
+362,890
| +26% | +$6.37M | 6.84% | 3 |
|
|
2015
Q4 | $25.9M | Sell |
1,403,360
-328,540
| -19% | -$5.89M | 6.65% | 5 |
|
|
2015
Q3 | $28.4M | Sell |
1,731,900
-32,100
| -2% | -$549K | 7.69% | 3 |
|
|
2015
Q2 | $31.2M | Sell |
1,764,000
-353,600
| -17% | -$6.32M | 7.97% | 3 |
|
|
2015
Q1 | $37.6M | Sell |
2,117,600
-575,000
| -21% | -$9.09M | 9.94% | 2 |
|
|
2014
Q4 | $35.7M | Buy |
2,692,600
+145,000
| +6% | +$1.85M | 7.94% | 3 |
|
|
2014
Q3 | $30.1M | Buy |
2,547,600
+30,000
| +1% | +$378K | 7.04% | 3 |
|
|
2014
Q2 | $32.1M | Buy |
2,517,600
+506,800
| +25% | +$6.59M | 7.61% | 3 |
|
|
2014
Q1 | $27.2M | Sell |
2,010,800
-584,000
| -23% | -$7.67M | 6.52% | 3 |
|
|
2013
Q4 | $31.2M | Buy |
2,594,800
+43,000
| +2% | +$508K | 8.41% | 2 |
|
|
2013
Q3 | $30M | Sell |
2,551,800
-1,005,200
| -28% | -$10.9M | 7.69% | 4 |
|
|
2013
Q2 | $33M | Buy |
+3,557,000
| New | +$30.2M | 9.62% | 3 |
|
Other funds holding BSX
Sector Gamma AS's BSX Position: Q2 2026 in Review
Sector Gamma AS opened a new position in Boston Scientific (BSX) in Q2 2026: 121,128 shares worth $5.17M. The stake represents 1.12% of the portfolio and ranks #31 among its holdings. This is a return to the name: Sector Gamma AS previously reported a position in BSX as recently as Q1 2023.
Sector Gamma AS first reported a position in BSX in Q2 2013 and has held it in 41 quarters since. The position peaked at $53.3M in Q3 2018. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Sector Gamma AS held 121,128 shares of Boston Scientific worth $5.17M as of Q2 2026.
- Boston Scientific was a new Sector Gamma AS position in Q2 2026.
- Boston Scientific made up 1.12% of Sector Gamma AS's portfolio in Q2 2026, its #31 holding.
- Sector Gamma AS first reported a position in Boston Scientific in Q2 2013 and has held it in 41 quarters since.
- Sector Gamma AS's Boston Scientific position peaked at $53.3M in Q3 2018.
- 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.